8-K
filed November 22, 2023, 6:59 PM ET
ticker LIPO
CIK 0001347242
other material
confidence high
sentiment neutral
materiality 0.15
Lipella shareholders elect all 7 directors, approve share plan increase, ratify auditor
LIPELLA PHARMACEUTICALS INC.
- Seven director nominees elected with ~2.22M to ~2.24M votes for each; 184,927 broker non-votes.
- Amendment to 2020 Stock Incentive Plan approved (1.57M for, 670k against); authorized shares increased by 1M to 2.4M.
- Ratification of Urish Popeck & Co. as independent auditor approved (2.42M for, 175 against).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
LIPELLA PHARMACEUTICALS INC. shareholders approved Amendment of 2020 Stock Incentive Plan to increase authorized shares by 1,000,000 at the 2023-11-21 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-11-21
Exact text from the filing
esults with respect to the election of each such nominee were as follows: Nominee For Withheld Broker Non-Votes Jonathan Kaufman 2,237,280 21,582 184,927 Michael Chancellor 2,232,180 26,682 184,927 Lori Birder 2,234,742 24,120 184,927 Daniel Cohen 2,234,742 24,120 184,927 Byong (Christopher) Kim 2,220,122 38,740 184,927 Ryan Pruchnic 2,234,842 24,020 184,927 Naoki Yoshimura 2,222,722 36,140 184,927 Proposal 2 – The
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
LIPELLA PHARMACEUTICALS INC. shareholders approved Election of seven director nominees at the 2023-11-21 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-11-21
Exact text from the filing
The seven (7) director nominees named in the Proxy Statement were elected by a plurality of the votes cast by holders of the shares present and entitled to vote at the Annual Meeting
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
LIPELLA PHARMACEUTICALS INC. shareholders approved Ratification of Urish Popeck & Co., LLC as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-11-21 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-11-21
Exact text from the filing
The appointment of Urish Popeck & Co., LLC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023, was ratified
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.